CFD and rheumatoid arthritis: The correlation between adipsin levels and disease duration in established-RA and axSpA patients suggests that adipsin might play a role in the progression of these diseases, consistent with previous studies indicating that chronic inflammation can modify adipokine profiles, leading to altered serum levels (4, 5, 7, 24).